SelectQuote, Inc. (NYSE:SLQT - Get Free Report) Director Donald Hawks III acquired 223,402 shares of the business's stock in a transaction that occurred on Monday, November 9th. The shares were bought at an average price of $0.46 per share, with a total value of $102,764.92. Following the completion of the transaction, the director directly owned 763,214 shares in the company, valued at approximately $351,078.44. The trade was a 41.39% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.
SelectQuote Price Performance
NYSE:SLQT traded up $0.01 during trading hours on Tuesday, reaching $0.46. 547,605 shares of the company traded hands, compared to its average volume of 1,550,047. The firm's 50-day moving average is $0.42 and its 200-day moving average is $0.75. The stock has a market cap of $82.28 million, a P/E ratio of -15.30 and a beta of 2.01. The company has a debt-to-equity ratio of 1.16, a current ratio of 7.48 and a quick ratio of 6.57. SelectQuote, Inc. has a 1-year low of $0.30 and a 1-year high of $1.76.
SelectQuote (NYSE:SLQT - Get Free Report) last released its quarterly earnings results on Wednesday, November 4th. The company reported ($0.21) earnings per share for the quarter, topping analysts' consensus estimates of ($0.33) by $0.12. SelectQuote had a return on equity of 22.48% and a net margin of 4.61%. The company had revenue of $280.01 million during the quarter, compared to analysts' expectations of $277.91 million. Equities research analysts expect that SelectQuote, Inc. will post -0.25 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
Several research firms have issued reports on SLQT. Wall Street Zen cut shares of SelectQuote from a "hold" rating to a "sell" rating in a research note on Saturday, August 29th. Weiss Ratings lowered shares of SelectQuote from a "sell (d+)" rating to a "sell (d)" rating in a research report on Monday, August 17th. Finally, Zacks Research upgraded SelectQuote from a "strong sell" rating to a "hold" rating in a report on Monday, October 26th. One equities research analyst has rated the stock with a Strong Buy rating, two have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, SelectQuote has a consensus rating of "Hold" and a consensus price target of $3.00.
Get Our Latest Report on SLQT
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently modified their holdings of the stock. BlackRock Inc. acquired a new stake in shares of SelectQuote during the 2nd quarter worth $1,836,000. GSA Capital Partners LLP acquired a new stake in SelectQuote during the second quarter worth about $1,123,000. Renaissance Technologies LLC increased its stake in SelectQuote by 817.6% during the first quarter. Renaissance Technologies LLC now owns 1,021,239 shares of the company's stock worth $643,000 after acquiring an additional 909,939 shares during the last quarter. Squarepoint Ops LLC purchased a new position in shares of SelectQuote in the 2nd quarter worth about $536,000. Finally, Connor Clark & Lunn Investment Management Ltd. purchased a new position in shares of SelectQuote in the 2nd quarter worth about $461,000. Institutional investors and hedge funds own 34.59% of the company's stock.
SelectQuote Company Profile
(
Get Free Report)
SelectQuote, Inc. NYSE: SLQT operates a technology-enabled insurance distribution platform that helps consumers compare and purchase insurance products from third-party carriers. The company combines digital tools, proprietary data and licensed agents to connect customers with coverage suited to their needs. SelectQuote's primary business is its Senior segment, which provides access to Medicare Advantage, Medicare Supplement and prescription drug plans. The company has also historically offered life insurance, as well as auto and home insurance, through its Life and Auto & Home businesses.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider SelectQuote, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SelectQuote wasn't on the list.
While SelectQuote currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.